non glp 1 drugs for weight loss Medicare Will Not Cover GLP-1 GLP-1 drugs: Lower dose or

GLP-1 was shown to manage blood sugar levels by improving insulin function, lowering glucagon levels, and delaying gastric emptying

[DOI] [PubMed] [Google Scholar] 88.Kawai T, et al

One month post-venous sinus stenting, there was no improvement in optic disc edema or visual fields, and visual acuity was further reduced to 20/70 in both eyes

20 This study is limited by the absence of indication data and the use of diagnostic codes, which may misclassify GLP-1RA use and underreport disease

Conflict of interest statement Within the last 36 months, FK has served on scientific advisory panels and/or been part of speaker's bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi and Zealand Pharma